![](/img/cover-not-exists.png)
Results of a prospective phase 2 pilot trial of Lu177 PSMA 617 therapy for metastatic castrate resistant prostate cancer including Imaging predictors of treatment response and patterns of progression.
Emmett, Louise, Crumbaker, Megan, Ho, Bao, Willowson, Kathy, Eu, Peter, Ratnayake, Lalith, Epstein, Richard, Blanksby, Ashley, Horvath, Lisa, Guminski, Alex, Mahon, Kate, Gedye, Craig, Yin, Charlotte,Language:
english
Journal:
Clinical Genitourinary Cancer
DOI:
10.1016/j.clgc.2018.09.014
Date:
September, 2018
File:
PDF, 1.65 MB
english, 2018